[P53 genes and solid tumors].

Abstract:

:The p53 gene is known to play a central role in cancer. In fact, no human tumor type is devoid of p53 mutations, although differences can be seen in the relative frequencies and patterns of nucleotide substitutions. Our work illustrates these differences, since frequencies of mutations ranged from 15 to 80% and the patterns of mutations were distinctly different in skin cancers compared to breast tumors. Furthermore, it is well established that whenever p53 mutations occur during tumor progression, their appearance greatly affects the natural evolution of cancer. This is confirmed by the correlations found between p53 mutations and the negative outcome of the disease in a number of tumor types.

journal_name

Bull Cancer

journal_title

Bulletin du cancer

authors

Theillet C

subject

Has Abstract

pub_date

1993-08-01 00:00:00

pages

693-6

issue

8

eissn

0007-4551

issn

1769-6917

journal_volume

80

pub_type

杂志文章
  • [Hepatocellular carcinoma: Increase in incidence or future plague?]

    abstract::Hepatocellular carcinoma is the third most frequent cause of cancer death worldwide, particularly in Asia and Africa. Most cases complicate an underlying liver cirrhosis due to hepatitis B or C chronic virus infection or alcoholic abuse. But, following the current epidemics of obesity and type 2 diabetes, it appears t...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:10.1016/j.bulcan.2018.02.003

    authors: Raoul JL,Raimbourg J,Hiret S,Adhoute X,Senellart H

    更新日期:2018-05-01 00:00:00

  • Open-label randomized multi-center phase 2 study: gemcitabine cisplatin plus avelumab or gemcitabine cisplatin as first-line treatment of patients with locally advanced or metastatic urothelial bladder carcinoma: GCisAve.

    abstract:BACKGROUND:The standard treatment in first line of advanced or metastatic urothelial bladder cancer (MBC) is the association of Gemcitabine and Cisplatin (GC). Avelumab, an anti-PD-L1 agent, has recently demonstrated efficacy. The objective is to evaluate the combination of these 3 agents. METHODS:This phase II random...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:10.1016/S0007-4551(20)30280-0

    authors: Gross-Goupil M,Domblides C,Lefort F,Ravaud A

    更新日期:2020-06-01 00:00:00

  • [Use of the functional imaging modalities in radiation therapy treatment planning in patients with glioblastoma].

    abstract::Glioblastoma multiforme still remains, at present, the most frequent and deadly primary malignant glioma in adult. Despite safer and larger neurosurgical resections, patients almost always relapse very close or inside the tumor bed. Since more than 20 years, radiation therapy (RT) continue delivering the same dose of ...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:

    authors: Dhermain F,Ducreux D,Bidault F,Bruna A,Parker F,Roujeau T,Beaudre A,Armand JP,Haie-Meder C

    更新日期:2005-04-01 00:00:00

  • [DNA form of the genome of oncornaviruses].

    abstract::The oncornaviruses share several biological, biochemical, and structural properties that distinguish them from other RNA viruses. Rous sarcoma virus, a representative of avian oncornaviruses, manifests two major functions: cell transformation and virus replication. Both functions are independent, and are expressed sep...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:

    authors: Hill M,Hillova J,Goubin G,Mariage R,Dantchev D

    更新日期:1975-04-01 00:00:00

  • [The use of deodorants/antiperspirants does not constitute a risk factor for breast cancer].

    abstract::Based on the observation of a high incidence of breast cancer in the upper outer quadrant adjacent to the usual area of application of deodorants and/or antiperspirants, several scientific teams have advanced the hypothesis of a possible link between antiperspirants and breast cancer. The possibility of the involvemen...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:10.1684/bdc.2008.0679

    authors: Namer M,Luporsi E,Gligorov J,Lokiec F,Spielmann M

    更新日期:2008-09-01 00:00:00

  • [Li-Fraumeni syndrome].

    abstract::The Li-Fraumeni syndrome is an autosomal dominant syndrome representing a genetic predisposition to a wide spectrum of tumours including sarcomas, breast carcinomas, brain tumors and adrenocortical carcinomas. In most of the cases, tumours will develop in children and young adults. Germline mutations of the tumor supp...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:

    authors: Frebourg T

    更新日期:1997-07-01 00:00:00

  • [Not Available].

    abstract::THE ROLE OF RUXOLITINIB IN THE TREATMENT OF MYELOPROLIFERATIVE NEOPLASMS: The discovery of the JAK2V617F mutation in 2005, present in 95% of polycythemia vera (PV) and in 55% of myelofibrosis (MF) patients, opened the way for a new era of targeted therapies for myeloproliferative neoplasms. Ruxolitinib was the first-i...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:10.1016/S0007-4551(16)30143-6

    authors: Soret J,Kiladjian JJ

    更新日期:2016-06-01 00:00:00

  • [What's new in the treatment of cancer pain?].

    abstract::Improvements have been made recently in the treatment of cancer pain. First of all, this symptom is better recognized and evaluated in cancer patients. Then new therapeutic options have became available in France : tramadol, WHO level II analgesic, for intermediate to severe pain; gabapentine, a new anticonvulsivant d...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:

    authors: Di Palma M,Poulain P,Pichard E

    更新日期:2004-01-01 00:00:00

  • [Treatment of soft tissue sarcomas in the adult with a combination of vindesine and cisplatin with doxorubicin or epirubicin: a pilot study].

    abstract::Twenty-five adult patients, 15 men and 10 women, with a median age of 49, and presenting with metastatic or locally advanced soft tissue sarcomas, have been treated with chemotherapy protocol combining cisplatinum, 100 mg/m2, vindesine, 4 mg/m2, and either adriamycin, 50 mg/m2 (APEL) (16 patients), or epirubicin, 100 ...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:

    authors: Becouarn Y,Bui BN,Kerbrat P,Chauvergne J,Brunet R,Robert J

    更新日期:1987-01-01 00:00:00

  • [Medicinal plants in cancer patients: current practices and evaluation data].

    abstract::Many complementary and alternatives medicines are offered to patients with cancer. Among them, herbal medicines have a substantial place. These plants are mainly used to reduce adverse effects of anticancer treatments and for specific anticancer properties. Our review shows that only few clinical data support medicina...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:10.1684/bdc.2013.1741

    authors: Huet M

    更新日期:2013-05-01 00:00:00

  • Immunothérapie des glioblastomes.

    abstract:IMMUNOTHERAPY IN GLIOBLASTOMAS:Targeting the immune system as a therapeutic strategy in solid tumors has shown great efficacy in various tumor types. However the role and success of this approach in glioblastomas remain to be determined. Recent studies demonstrated that central nervous system is no longer considered as...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:10.1016/S0007-4551(18)30391-6

    authors: Baldini C,Romano PM,Varga A,Champiat S,Dumont S,Dhermain F,Louvel G,Marabelle A,Postel-Vinay S,Angevin E,Gazzah A,Ribrag V,Bahleda R,Michot JM,Hollebecque A,Soria JC,Massard C

    更新日期:2018-12-01 00:00:00

  • [Insufficient efficacy of the use of a single 8 mg tablet of ondansetron in the prevention of nausea and vomiting induced by FEC chemotherapy].

    abstract::This study was performed in a group of 89 patients treated for breast carcinoma with a FEC regimen (5-fluorouracil, epirubicin, cyclophosphamide). The aim was to evaluate the antiemetic efficacy of one 8 mg tablet ondansetron (OND), and in case of failure, to measure the recovering level by the administration of 8 mg ...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:

    authors: Hebbar M,Hecquet B,Vanlemmens L,Lecomte S,Pion JM,Adenis A,Bonneterre J

    更新日期:1995-01-01 00:00:00

  • [Portal vein embolization: Present and future].

    abstract::Portal vein embolization consists of occluding a part of the portal venous system in order to achieve the hypertrophy of the non-embolized liver segments. This technique is used during the preoperative period of major liver resection when the future remnant liver (FRL) volume is insufficient, exposing to postoperative...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:10.1016/j.bulcan.2017.03.009

    authors: Piron L,Deshayes E,Escal L,Souche R,Herrero A,Pierredon-Foulongne MA,Assenat E,le Lam N,Quenet F,Guiu B

    更新日期:2017-05-01 00:00:00

  • [Mechanisms and role of lymphangiogenesis in cancer metastasis].

    abstract::An important critical point in tumor progression is the acquisition of metastatic potential. The presence of metastases in regional lymph nodes is an indicator of poor survival. The vascular endothelial growth factor (VEGF) family of growth factors and receptors is involved in vasculogenesis and angiogenesis. Among th...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:

    authors: Dupuy E,Tobelem G

    更新日期:2003-07-01 00:00:00

  • [Is bone scan useful in patients with breast cancer localized on the basis of clinical examination. 143 cases (author's transl)].

    abstract::The authors present 143 cases of breast carcinoma T1 and T2, N0, N1, N2 and N3 without clinical signs of bone metastasis. They study the value of bone scintigraphy with technetium 99m labelled diphosphonates. One hundred and twelve patients had normal bone scans; 31 patiets showed abnormal fixation sites: in 23 (16%) ...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:

    authors: Stines J,Stalars J,Dartois D,Chardot C

    更新日期:1980-01-01 00:00:00

  • An interim assessment of the experience of fast neutron boost in inoperable rectal carcinomas in Orléans.

    abstract::Since January 1981, 58 patients with postoperative recurrences or inoperable rectal cancer have been included in a trial featuring a neutron boost after an initial series of irradiation given by the classical high energy photon procedure. This group irradiated at the Neutrontherapy Unit in Orléans was compared to a hi...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:

    authors: Breteau N,Destembert B,Favre A,Sabattier R,Schlienger M

    更新日期:1986-01-01 00:00:00

  • [Technical considerations for KRAS testing in colorectal cancer. The biologist's point of view].

    abstract::Targeted therapy against the EGF receptor was shown to be effective in a subgroup of patients with KRAS wild-type colorectal cancer. Therefore, cetuximab (Erbitux) or panitumumab (Vectibix) obtained the authorization by the EMEA restricted to patients with KRAS wild-type tumours. KRAS mutational testing has become par...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:10.1684/bdc.2009.0996

    authors: Blons H,Laurent-Puig P

    更新日期:2009-12-01 00:00:00

  • [Hospital teaching of oncology].

    abstract::Theoretical teaching of oncology was improved, 15 years ago, by individualizing a special university course during medical studies in France. However medical students need also practical exercising by relation with cancer patients. The main goals may be defined and given to students at the beginning of practical cours...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:

    authors: Hoerni B,Vrousos C

    更新日期:1985-01-01 00:00:00

  • [Translation and validation of Brief Edinburgh Depression Scale (BEDS) in French].

    abstract:BACKGROUND:Depression is an important symptom for many palliative care patients but is rarely identified. It's known to reduce quality of life and impact on palliation of physical symptom. These physical symptoms can be improved by an adequate treatment of depression. Many depressed cancer patients are not treated due ...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:10.1684/bdc.2011.1310

    authors: Rhondali W,Perceau E,Saltel P,Girard R,Filbet M

    更新日期:2011-02-01 00:00:00

  • [The frequency of cancer in France: all ages and under age 15, mortality in 2003 and trends since 1968].

    abstract::In 2003, there was 147,000 deaths attributed to cancer in France, 88,000 in men and 59,000 in women. Cancer mortality rates have been decreasing since 1987 in the male population and since the late 60's in the female population, the decrease is larger for the male population. This decrease is observed for most sites o...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:

    authors: Hill C,Doyon F

    更新日期:2007-01-01 00:00:00

  • [Is AP24534 (Ponatinib) the next treatment of Philadelphia chromosome-positive acute lymphoblastic leukemia?].

    abstract::Distinct clinicopathologic acute lymphoblastic leukemia (ALL) entities have been identified, resulting in the adoption of risk-oriented treatment approaches. In Philadelphia chromosome-positive (Ph(+)) ALL, the optimal treatment requires the addition of BCR-ABL tyrosine kinase inhibitors, as imatinib. However, the out...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:10.1684/bdc.2011.1390

    authors: Thomas X

    更新日期:2011-07-01 00:00:00

  • [Metastatic breast cancer: controlled trial of chemotherapy with and without hormones].

    abstract::Two hundred and twenty-three patients with disseminated breast cancer entered in a randomized trial: Group I: 130 patients were given a monthly 5 day- course of a cytotoxic chemotherapy protocol including Adriamycine, Vincristine, Cyclophosphamide, 5 Fluoro-uracile (A.V.L.F.); Group II: 93 patients were given alternat...

    journal_title:Bulletin du cancer

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:

    authors: Jouve M,Palangie T,Garcia-Giralt E,Bretaudeau B,Magdelenat H,Asselain B,Pouillart P

    更新日期:1984-01-01 00:00:00

  • A phase II trial of early intensive chemotherapy with autologous bone marrow transplantation in the treatment of poor prognosis non seminomatous germ cell tumors.

    abstract::Twenty-eight patients with poor prognosis, advanced metastatic non seminomatous germ cell tumors (NSGCT) were treated with early high dose chemotherapy and autologous bone marrow transplantation (ABMT) rescue. The primary tumor was testicular in 19 patients and extragonadal in nine patients. For 19 patients with a tes...

    journal_title:Bulletin du cancer

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:

    authors: Droz JP,Pico JL,Ghosn M,Kramar A,Rey A,Ostronoff M,Baume D

    更新日期:1992-01-01 00:00:00

  • [Not Available].

    abstract:SURGICAL DE-ESCALATION FOR INVASIVE BREAST CANCER TREATMENT:A surgical therapeutic de-escalation is going to continue but necessarily has to design in a progressive careful way and especially arranged with the other practitioners and therapeutic methods. These strategies concern as well the surgery of the breast as tha...

    journal_title:Bulletin du cancer

    pub_type: 社论

    doi:10.1016/S0007-4551(16)30151-5

    authors: Houvenaeghel G,Cohen M,Bannier M,Jauffret C,Buttarelli M,Lambaudie E

    更新日期:2016-06-01 00:00:00

  • [Importance of a multidisciplinary approach to metastatic cancer of the rectum].

    abstract::Management of rectal cancers with synchronous metastasis is difficult. We evaluated in 23 patients a combination of pelvic radiotherapy at the dose of 45 Gy in 5 weeks and 25 fractions with chemotherapy by 5-fluorouracil (350 mg/m2/day) and folinic acid (20 mg/m2/day) for 5 days at the time of the first and the fifth ...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:

    authors: Mitry E,Pompili PL,Rougier P,Toma C,Ducreux M,Lusinchi A,Elias D,Fabri MC,Bourhis J,Kac J,Eschwege F,Lasser P

    更新日期:1998-08-01 00:00:00

  • High negative predictive value of slow lymphatic drainage on metastatic node spread detection in malignant limb and trunk cutaneous melanoma.

    abstract:AIM:Harvesting of the "sentinel lymph node" (SLN) as identified by lymphoscintigraphy (LSG) is becoming increasingly important in the staging of patients with malignant melanoma. The purpose of the current study was to determine whether the appearance time of the LSG had a prognostic value in predicting metastasis diss...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:

    authors: Cammilleri S,Jacob T,Rojat-Habib MC,Hesse S,Berthet B,Giorgi R,Bonerandi JJ,Mundler O

    更新日期:2004-07-01 00:00:00

  • Targeting DNA methylation in cancer.

    abstract::Cancer growth and metastasis require the coordinate change in gene expression of different sets of genes. While genetic alterations can account for some of these changes, many of the changes in gene expression observed in cancer are caused by epigenetic modifications. The epigenome consists of the chromatin and its mo...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:

    authors: Szyf M

    更新日期:2006-09-01 00:00:00

  • [Symptomatic management of brain metastasis].

    abstract::Indications and choice of antiepileptic drugs (AED), treatments for cerebral edema and prophylactic and curative treatments of thromboembolic complications of brain metastasis are discussed. ...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:10.1684/bdc.2012.1689

    authors: Le Rhun E,Taillandier L,Beauchene P,Bailon O,Dubois F

    更新日期:2013-01-01 00:00:00

  • [Epidemiology of HIV-associated malignancies].

    abstract::Human immunodeficiency virus (HIV)-associated malignancies include acquired immunodeficiency virus: Aids-defining malignancies, Kaposi's sarcoma, (KS), non-Hodgkin's lymphoma (NHL), and, since 1993, invasive cervical cancer (1CC), and non-Aids defining malignancies. Most cancers that are associated with HIV infection ...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:

    authors: Launay O,Guillevin L

    更新日期:2003-05-01 00:00:00

  • [Colorectal cancers disclosed by an obstruction. Frequency and prognosis in a population].

    abstract::The registry of digestive tumors of the department of Cote-d'Or recorded between 1976 and 1982, among 1543 colorectal cancers, 142 cases (9.2%) diagnosed with acute obstruction. Distribution of the tumors along the large bowel was as follows: rectal cancers were rarely obstructive (3.8%) whereas it was a more common f...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:

    authors: Boutron MC,Faivre J,Rallier du Baty H,Meny B,Bedenne L,Hillon P,Klepping C

    更新日期:1988-01-01 00:00:00